MS Speaks

Multiple Sclerosis => TREATMENTS => KESIMPTA (ofatumumab) => Topic started by: agate on May 13, 2026, 03:10:32 pm

Title: (Abst.) Ofatumumab and enteroviral encephalitis: A severe infectious complication...
Post by: agate on May 13, 2026, 03:10:32 pm

From PubMed (April 13, 2026)--"Ofatumumab and enteroviral encephalitis: A severe infectious complication as a class effect with anti-CD20 therapies":


https://pubmed.ncbi.nlm.nih.gov/42116738/